Auris Health, Inc.

Abbott Cardiovascular Systems, Inc.

Medical University of South Carolina

Alexander James Sheehy

Eugene T Michal

Shubhayu Basu

Chauncey F Graetzel

Prasanth Jeevan

Hedyeh Rafii-Tari

Francis G Spinale

Melissa A Teran

Jeffery David Howard

Miroslav Drahos

Nicolas E Robert

Rupak Mukherjee

Andrew Esbenshade Zeldis

René Ango Mambembe

Douglas T Boyd

Stephen D Pacetti

O Mikael Trollsas

Certain aspects relate to systems and techniques for driving a medical instrument having an inner body and an outer body. In one aspect, a system includes a medical instrument comprising an outer body and an inner body configured to be driven through a lumen in the outer body. The system may further include a set of one or more instrument manipulators configured to control movement of the outer and inner bodies and a set of one or more processors configured to: receive a change drive mode command, and in response to receiving the change drive mode command, change a drive mode of the medical instrument from a paired drive mode to an unpaired drive mode.

System and method for driving medical instrument

Certain aspects relate to systems and techniques for medical instrument navigation and targeting. In one aspect, a system includes a medical instrument having an elongate body and at least one sensor, a display, a processor, and a memory storing a model of a mapped portion of a luminal network and a position of a target with respect to the model. The processor may be configured to: determine, based on data from the at least one sensor, a position and orientation of a distal end of the medical instrument with respect to the model, and cause, on at least a portion of the display, a rendering of the model, the position of the target, and the position and orientation of the distal end of the medical instrument. The rendering may be based on a viewpoint directed at the target and different from a viewpoint of the medical instrument.

System and method for medical instrument navigation and targeting

A bioscaffolding can be formed within a post-myocardial infarct region sufficient to cause attenuation of a rate of myocardial infarct expansion. A bioscaffolding may further be formed in the post-myocardial infarct region to cause an increase in posterior left ventricular wall thickness. The gel or bioscaffolding can be formed from a mixture of gel components of different gelation systems. For example, a bioscaffolding can be formed by mixing at least two different components of at least two different two-component gelation systems to form a first mixture and by mixing at least two different components (other than the components that make up the first mixture) of the at least two different two-component gelation systems to form a second mixture.

Composition for modifying myocardial infarction expansion

Coatings for medical devices, the coatings including albumin, the methods of forming the coatings, and the coated medical devices are disclosed. In preferred embodiments the medical device is a bioabsorbable stent. The albumin coating layer improves the thromboresistance of the device.

Stent with albumin coating for enhanced thromboresistance

Methods of modifying myocardial infarction expansion

Growing community of inventors

Redwood City, CA, United States of America

Alexander James Sheehy